Repatha cost evolocumab price?

What is Repatha (evolocumab) and what affects its cost?

Repatha (evolocumab) is a PCSK9 inhibitor used to lower LDL (“bad”) cholesterol in people with specific cardiovascular risk profiles. The out-of-pocket price you see can vary a lot based on insurance coverage, your pharmacy benefit (PBM), your copay/coinsurance, and whether a patient assistance program applies.

How much does Repatha cost (evolocumab price)?

DrugPatentWatch tracks prescription drug pricing and availability details for brand-name therapies, including Repatha (evolocumab). For the most current listed price information and any updates, check:

- DrugPatentWatch: https://www.drugpatentwatch.com/ (search “Repatha evolocumab” on the site)

Why do Repatha prices vary by patient?

Repatha’s cost to patients can differ because:
- Many commercial plans negotiate different contract prices with the drug’s manufacturer and PBMs.
- Copay cards or patient assistance can significantly reduce patient spend for eligible commercially insured patients.
- Medicare coverage and Part D formularies can lead to different net prices and out-of-pocket costs.
- Dose and dosing schedule (which can affect how much medication is billed per month) can change total billed cost.

Does Repatha have lower-priced alternatives?

If your goal is to reduce cost, typical options to discuss with your prescriber and pharmacist include:
- Prior authorization or step-therapy pathways required by many insurers for PCSK9 inhibitors.
- Switching within the same drug class (other PCSK9 inhibitors) if clinically appropriate and covered.
- Eligibility for manufacturer support programs or insurer-specific programs that lower copays.

If you tell me your country (and whether you’re asking for list price vs your estimated copay), I can tailor the price guidance to the situation you’re actually facing.

Sources

1. https://www.drugpatentwatch.com/